• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Sophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.031.

作者信息

Montorsi Francesco, Bravi Carlo Andrea, Gandaglia Giorgio, Mottrie Alexandre, Briganti Alberto

机构信息

Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; ORSI Academy, Ghent, Belgium; Department of Urology, Onze-Lieve-Vrouwziekenhuis Hospital, Aalst, Belgium.

出版信息

Eur Urol. 2022 Nov;82(5):e148. doi: 10.1016/j.eururo.2022.07.036. Epub 2022 Sep 2.

DOI:10.1016/j.eururo.2022.07.036
PMID:36064476
Abstract
摘要

相似文献

1
Re: Sophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.031.
Eur Urol. 2022 Nov;82(5):e148. doi: 10.1016/j.eururo.2022.07.036. Epub 2022 Sep 2.
2
Re: Sophie Knipper, Mehrdad Mehdi Irai, Ricarda Simon, et al. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery. Eur Urol 2022;83:62-9.
Eur Urol. 2023 May;83(5):e139. doi: 10.1016/j.eururo.2023.01.029. Epub 2023 Feb 14.
3
Re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.040: Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer.
Eur Urol. 2021 May;79(5):e154-e156. doi: 10.1016/j.eururo.2021.02.024. Epub 2021 Feb 23.
4
Re: Karim A. Touijer, Daniel D. Sjoberg, Nicole Benfante, et al. Limited Versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2021.03.006.
Eur Urol Oncol. 2021 Oct;4(5):852-853. doi: 10.1016/j.euo.2021.07.007. Epub 2021 Sep 15.
5
Metastases-yield and Prostate-specific Antigen Kinetics Following Salvage Lymph Node Dissection for Prostate Cancer: A Comparison Between Conventional Surgical Approach and Prostate-specific Membrane Antigen-radioguided Surgery.挽救性淋巴结清扫术后前列腺癌转移率和前列腺特异抗原动力学：传统手术方法与前列腺特异膜抗原放射性导向手术的比较。
Eur Urol Focus. 2019 Jan;5(1):50-53. doi: 10.1016/j.euf.2018.09.014. Epub 2018 Oct 3.
6
Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039.回复：乔治·甘达利亚、阿尔贝托·布里甘蒂、诺埃尔·克拉克等人。前列腺癌患者根治性前列腺切除术后的辅助放疗和挽救性放疗。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2017.01.039
Eur Urol. 2017 Aug;72(2):e39-e40. doi: 10.1016/j.eururo.2017.03.004. Epub 2017 Mar 18.
7
Re: Jeffrey J. Tosoian, Mufaddal Mamawala, Jonathon I. Epstein, et al. Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.017.回复：杰弗里·J·托索扬、穆法达尔·马马瓦拉、乔纳森·I·爱泼斯坦等。1级前列腺癌的主动监测：大型前瞻性队列的长期结果。《欧洲泌尿外科杂志》。即将发表。https://doi.org/10.1016/j.eururo.2019.12.017
Eur Urol. 2020 Aug;78(2):e91. doi: 10.1016/j.eururo.2020.03.010. Epub 2020 May 4.
8
Re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010.
Eur Urol. 2021 Jul;80(1):e14. doi: 10.1016/j.eururo.2021.04.011. Epub 2021 Apr 30.
9
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019.
Eur Urol. 2022 May;81(5):e121. doi: 10.1016/j.eururo.2021.12.042. Epub 2022 Feb 4.
10
Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019.
Eur Urol. 2022 Jul;82(1):e15-e16. doi: 10.1016/j.eururo.2022.03.032. Epub 2022 Apr 12.

引用本文的文献

1
Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection.前列腺特异性膜抗原靶向手术治疗前列腺癌：准确识别、实时诊断和精确切除。
Theranostics. 2024 Apr 22;14(7):2736-2756. doi: 10.7150/thno.95039. eCollection 2024.